Abstract
Objective Physical activity is known to reduce the risk of disability, disease, and mortality. However, in some patients, an excessive, irrational, and debilitating fear of movement (i.e., kinesiophobia) is thought to induce avoidance behaviors, contributing to decreased engagement in physical activity. The aim of this study was to examine whether kinesiophobia is negatively associated with physical activity and what factors influence this relationship.
Methods Three databases were searched for articles including both a measure of kinesiophobia and physical activity. Two reviewers screened articles for inclusion, assessed risk of bias, and extracted data from each study. Pearson product-moment correlations were pooled from eligible studies using the generic inverse pooling and random effects method to examine the relationship between kinesiophobia and physical activity.
Results Forty-nine articles were included in the systematic review and 41 studies (n = 4,848) in the meta-analysis. Results showed a moderate negative correlation between kinesiophobia and physical activity (r = -0.31; 95% CI: -0.42 to -0.20; I2 = 1.8%; p < 0.0001). Subgroup meta-analyses revealed that the correlation was statistically significant only in patients with a cardiovascular or arthritis condition and in studies using a self-reported measure of physical activity. There was no evidence of an effect of age, gender, or pain.
Conclusions Higher levels of kinesiophobia were moderately associated with lower levels of physical activity. However, between-study heterogeneity was considerable, and results showed no evidence of this association when physical activity was assessed with accelerometers or pedometers. Additional studies using device-based measures of physical activity are required to confirm these results and to understand the factors and mechanisms influencing this potential relationship.
Impact Our results suggest that kinesiophobia could be considered as a limiting factor when developing physical activity promotion strategies for inactive patients.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022364063
Funding Statement
Matthieu P. Boisgontier is supported by Natural Sciences and Engineering Research Council of Canada (NSERC; RGPIN-2021-03153), the Canada Foundation for Innovation (CFI), Mitacs, and the Banting Research Foundation. Ata Farajzadeh is supported by an Admission Scholarship, a Doctoral International Scholarship, and a Special Merit Scholarship from the University of Ottawa, and by a BMO Graduate Scholarship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data, scripts, and materials used in the present study are available online at https://doi.org/10.5281/zenodo.8216112. The study was pre-registered in PROSPERO: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022364063
